<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136-pharmaceuticals-13-00096">
 <label>136.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Vedantham</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Agudelo</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Carrion</surname>
    <given-names>R.</given-names>
    <suffix>Jr.</suffix>
   </name>
   <name>
    <surname>Nunneley</surname>
    <given-names>J.W.</given-names>
   </name>
   <name>
    <surname>Barnard</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Pohlmann</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>McKerrow</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Renslo</surname>
    <given-names>A.R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Protease inhibitors targeting coronavirus and filovirus entry</article-title>
  <source>Antivir. Res.</source>
  <year>2015</year>
  <volume>116</volume>
  <fpage>76</fpage>
  <lpage>84</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.01.011</pub-id>
  <pub-id pub-id-type="pmid">25666761</pub-id>
 </element-citation>
</ref>
